Unlike conventional cytokines, IL-33 is typically released by epithelial cells following damage to barrier tissue and binds to ST2 that forms a heterodimer with IL-1RAcP (45, 46) to serve as an alarmin in response to inflammation and infection (47–49). The gene discussed is IL33; the disease is infection.